Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1950 2
1951 1
1953 2
1954 2
1956 3
1958 1
1960 1
1963 1
1964 1
1966 1
1982 1
1997 1
2002 1
2003 1
2004 5
2005 4
2006 4
2007 3
2008 4
2009 3
2010 4
2011 2
2012 3
2013 2
2014 4
2015 4
2016 10
2017 13
2018 14
2019 17
2020 17
2021 17
2022 17
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
A practical approach to uveitis screening in children with juvenile idiopathic arthritis.
Foeldvari I, Bohn M, Petrushkin H, Angeles Han S, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer JH, Díaz-Cascajosa J, Edelsten C, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, Saurenmann RK, Simonini G, Solebo AL, Titz J, Anton J. Foeldvari I, et al. Among authors: constantin t. Br J Ophthalmol. 2024 Apr 4:bjo-2023-324406. doi: 10.1136/bjo-2023-324406. Online ahead of print. Br J Ophthalmol. 2024. PMID: 38575198
Vaccination proposal for patients on onasemnogene abeparvovec therapy.
Dobner S, Kulcsár A, Liptai Z, Vojnisek Z, Constantin T, Szabó L. Dobner S, et al. Among authors: constantin t. Eur J Paediatr Neurol. 2024 Mar;49:95-99. doi: 10.1016/j.ejpn.2024.02.010. Epub 2024 Mar 1. Eur J Paediatr Neurol. 2024. PMID: 38457958 Free article. Review.
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai CF, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL. Constantin TA, et al. Br J Cancer. 2024 Mar;130(5):892. doi: 10.1038/s41416-024-02606-w. Br J Cancer. 2024. PMID: 38355841 Free PMC article. No abstract available.
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022.
Foeldvari I, Torok KS, Antón J, Blakley M, Constantin T, Cutolo M, Denton CP, Fligelstone K, Hinrichs B, Li SC, Maillard S, Marrani E, Moinzadeh P, Orteu CH, Pain CE, Pauling JD, Pilkington C, Rosser F, Smith V, Furst DF. Foeldvari I, et al. Among authors: constantin t. Expert Rev Clin Immunol. 2024 Apr;20(4):387-404. doi: 10.1080/1744666X.2023.2298354. Epub 2024 Jan 2. Expert Rev Clin Immunol. 2024. PMID: 38149621 Review.
Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.
Foeldvari I, Torok KS, Anton J, Blakley M, Constantin T, Curran M, Cutolo M, Denton C, Fligelstone K, Ingegnoli F, Li SC, Němcová D, Orteu C, Pilkington C, Smith V, Stevens A, Klotsche J, Khanna D, Costa-Reis P, Del Galdo F, Hinrichs B, Kasapcopur O, Pain C, Ruperto N, Zheng A, Furst DE. Foeldvari I, et al. Among authors: constantin t. Arthritis Care Res (Hoboken). 2023 Dec;75(12):2453-2462. doi: 10.1002/acr.25171. Epub 2023 Sep 12. Arthritis Care Res (Hoboken). 2023. PMID: 37332054 Review.
160 results